Juris Hmelnickis
Chief Executive Officer at GRINDEKS
Profile
Juris Hmelnickis is currently the Chairman-Management Board at Grindeks.
AS and a Member-Management Board at Kalceks AS.
He obtained a doctorate degree from the University of Latvia in 2010, a graduate degree from the University of Latvia in 2004, and another graduate degree from Riga Technical University in 2005.
Juris Hmelnickis active positions
| Companies | Position | Start |
|---|---|---|
| GRINDEKS | Chief Executive Officer | 2020-02-03 |
Kalceks AS
 Kalceks AS Pharmaceuticals: MajorHealth Technology Part of Grindeks AS, Kalceks AS is a pharmaceutical company based in Riga, Latvia. Kalceks manufactures pharmaceutical products. The Latvian company was founded in 1920. Egils Kopstals has been the CEO of the private company since 2020. Kalceks was acquired by Grindeks AS on May 09, 2005. | Corporate Officer/Principal | 2020-02-17 |
Training of Juris Hmelnickis
| University of Latvia | Graduate Degree |
| Riga Technical University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Grindeks AS
 Grindeks AS Pharmaceuticals: MajorHealth Technology Grindeks AS produces pharmaceutical, medical, and phytochemical medicine. It engages in the research, development, manufacturing, and sales of original products, generics, and active pharmaceutical ingredients. The company specializes in the heart and cardiovascular, central nervous system, and anti-cancer medication therapeutic groups. Grindeks was founded in 1946 and is headquartered in Riga, Latvia. | Health Technology |
Kalceks AS
Kalceks AS Pharmaceuticals: MajorHealth Technology Part of Grindeks AS, Kalceks AS is a pharmaceutical company based in Riga, Latvia. Kalceks manufactures pharmaceutical products. The Latvian company was founded in 1920. Egils Kopstals has been the CEO of the private company since 2020. Kalceks was acquired by Grindeks AS on May 09, 2005. | Health Technology |
- Stock Market
- Insiders
- Juris Hmelnickis
